Synthesis of S-[13N]nitrosoglutathione (13N-GSNO) as a new potential PET imaging agent

Applied Radiation and Isotopes

Volumn 67, Issue 1, 2009, Pages 95-99

  Llop, Jordi ^a   Gómez Vallejo, Vanessa ^a   Bosque, Marta ^a   Quincoces, Gemma ^b   Peñuelas, Iván ^b  

^a Barcelona Biomedical Research Park   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

13N; GSNO; Nitric oxide; NO donor; PET; S nitrosothiols

Indexed keywords

ACIDS; ETHANOL; HYDROCHLORIC ACID; NITRIC OXIDE; NUCLEAR REACTORS; SULFUR COMPOUNDS;

13N; GSNO; NO DONOR; PET; S-NITROSOTHIOLS;

POSITRON EMISSION TOMOGRAPHY;

GLUTATHIONE; NITRIC OXIDE; NITROGEN 13; S NITROSOGLUTATHIONE N 13; S NITROSOTHIOL; UNCLASSIFIED DRUG; WATER; DIAGNOSTIC AGENT; NITROGEN; RADIOPHARMACEUTICAL AGENT; S NITROSOGLUTATHIONE;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHEMICAL STRUCTURE; CYCLOTRON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NITROSATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHEMISTRY; REACTION TIME; SYNTHESIS; ISOTOPE LABELING; METHODOLOGY; SOLUTION AND SOLUBILITY;

ISOTOPE LABELING; NITROGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; S-NITROSOGLUTATHIONE; SOLUTIONS; WATER;

EID: 56649105054     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2008.09.014     Document Type: Article

References (20)

1. Al-Sa'doni H., and Ferro A. S-nitrosothiols: a class of nitric oxide-donor drugs. Clin. Sci. 98 5 (2000) 507-520
2. Al-Sa'doni H.H., and Ferro A. Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols. Min. Rev. Med. Chem. 5 3 (2005) 247-254
3. Coppola L., Grassia A., Giunta R., Verrazzo G., Cava B., Tirelli A., and D'Onofrio F. Glutathione (GSH) improved haemostatic and haemorheological parameters in atherosclerotic subjects. Drugs Exp. Clin. Res. 18 11-12 (1992) 493-498
4. De Mattia G., Bravi M.C., Laurenti O., Cassone-Faldetta M., Armiento A., Ferri C., and Balsano F. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 47 8 (1998) 993-997
5. Ikarugi H., Inoue A., Yamashita T., Tsuda Y., Okada Y., Ishii H., and Yamamoto J. Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor. Thromb. Res. 116 5 (2005) 403-408
6. Khan M., Jatana M., Elango C., Paintlia A.S., Singh A.K., and Singh I. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15 2 (2006) 114-124
7. Kowaluk E.A., and Fung H.L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255 3 (1990) 1256-1264
8. Kuo Y.R., Wang F.S., Jeng S.F., Huang H.C., Wei F.C., and Yang K.D. Nitrosoglutathione modulation of platelet activation and nitric oxide synthase expression in promotion of flap survival after ischemia/reperfusion injury. J. Surg. Res. 119 1 (2004) 92-99
9. Mathews W.R., and Kerr S.W. Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267 3 (1993) 1529-1537
10. Molloy J., Martin J.F., Baskerville P.A., Fraser S.C., and Markus H.S. S-nitrosoglutathione reduces the rate of embolization in humans. Circulation 98 14 (1998) 1372-1375
11. 13N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripherals artery occlusive disease. J. Nucl. Med. 48 7 (2007) 1216-1223
12. Salas E., Langford E.J., Marrinan M.T., Martin J.F., Moncada S., and de Belder A.J. S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. Heart 80 2 (1998) 146-150
13. Scatena R., Bottoni P., Martorana G.E., and Giardina B. Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. Expert Opin. Invest. Drugs 14 7 (2005) 835-846
14. Sechi G., Deledda M.G., Bua G., Satta W.M., Deiana G.A., Pes G.M., and Rosati G. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 20 7 (1996) 1159-1170
15. Thabano J.R., Abong'o D., and Sawula G.M. Determination of nitrate by suppressed ion chromatography after copperised-cadmium column reduction. J. Chromatogr. A. 1045 1-2 (2004) 153-159
16. Tsikas D., Sandmann J., Rossa S., Gutzki F.M., and Frölich J.C. Investigations of S-transnitrosylation reactions between low- and high-molecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal. Biochem. 270 2 (1999) 231-241
17. Vodovotz Y., Waksman R., Cook J.A., Kim W.H., Chan R., Seabron R., Collins S.D., Pierre A., Bramwell O., Wink D., Mitchell J.B., and Leon M.B. S-nitrosoglutathione reduces nonocclusive thrombosis rate following balloon overstretch injury and intracoronary irradiation of porcine coronary arteries. Int. J. Radiat. Oncol. Biol. Phys. 48 4 (2000) 1167-1174
18. 13N] ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures. Int. J. Radiat. Appl. Instrum. A 42 11 (1991) 1095-1098
19. Wijns W., and Camici P.G. The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease. Herz 22 2 (1997) 87-95
20. Williams D.L.H. Nitric oxide release from S-nitrosothiols (RSNO)-the role of copper ions. Transition Met. Chem. 21 (1996) 189-191